Unifaith Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 21-06-2024
- Paid Up Capital ₹ 1.50 M
as on 21-06-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 35.78%
(FY 2023)
- Profit 123.98%
(FY 2023)
- Ebitda 62.70%
(FY 2023)
- Net Worth 336.21%
(FY 2023)
- Total Assets 21.60%
(FY 2023)
About Unifaith Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Dharam Sharma, Upasna Dewan, and Jai Dewan serve as directors at the Company.
- CIN/LLPIN
U74999DL2020PTC363917
- Company No.
363917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Unifaith Biotech Private Limited offer?
Unifaith Biotech Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Antibacterial Drugs, Antibiotic Tablets, Capsule & Syrup, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Common Disease Medicines, Injectable Products, Pharmaceutical Medicine.
Who are the key members and board of directors at Unifaith Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharam Sharma  | Director | 23-May-2020 | Current |
| Upasna Dewan | Director | 23-May-2020 | Current |
| Jai Dewan | Director | 12-May-2022 | Current |
Financial Performance of Unifaith Biotech.
Unifaith Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.78% increase. The company also saw a substantial improvement in profitability, with a 123.98% increase in profit. The company's net worth Soared by an impressive increase of 336.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unifaith Biotech?
Unlock access to Unifaith Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unifaith Biotech?
Unifaith Biotech has a workforce of 55 employees as of May 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unifaith Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unifaith Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
